The benefits of GLP-1 medications in (overweight or obese) women with PCOS may include: While we need more research on GLP-1s and fertility in non-PCOS populations and women seeking fertility treatments, there is ample evidence for women with PCOS using GLP-1 medications for weight loss that the benefits extend to fertility as well
GLP-1 receptor agonists mimic this hormone by binding to GLP-1 receptors throughout the body, including the pancreas, brain, stomach, and other organs
Its only available as a medication for people living with type 2 diabetes
Semaglutide (Wegovy, Ozempic, compounded) Semaglutide has the longest treatment duration data among current GLP-1 options
Melissa received a Bachelor of Arts in Nutrition (DPD) from the College of Saint Benedict and completed her dietetic internship through Iowa State University
The first incretin-based drug approved specifically for weight loss was liraglutide (Saxenda), developed by Novo Nordisk